Allograft arteriopathy: Pathogenesis update

Cardiovascular Pathology

Volumn 13, Issue 1, 2004, Pages 33-40

  Mitchell, Richard N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Arteriopathy; Atherosclerosis; Chemokine; Cytokine; Immunology; Rejection; Transplantation

Indexed keywords

CHEMOKINE; CYTOKINE;

ALLOGRAFT; ALLOIMMUNITY; ARTERY DISEASE; ATHEROSCLEROSIS; CELLULAR IMMUNITY; HISTOLOGY; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; ORGAN TRANSPLANTATION; PATHOGENESIS; PRECURSOR; PRIORITY JOURNAL; PROTEIN FUNCTION; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER;

EID: 0842348160     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(03)00108-X     Document Type: Review

References (105)

1. Costanzo M., Naftel D., Pritzker M., Heilman J., Boehmer J., Brozena S., Dec G., Ventura H., Kirklin J., Bourge R. Heart transplant coronary artery disease detected by coronary angiography: a multi-institutional study of preoperative donor and recipient risk factors. J Heart Lung Transplant. 17:1998;744-753.
2. Hosenpud J., Bennett L., Keck B., Fiol B., Boucek M., Novick R. The registry of the International Society for Heart and Lung Transplantation: fifteenth official report - 1998. J Heart Lung Transplant. 17:1998;656-668.
3. Schoen F., Libby P. Cardiac transplant graft arteriosclerosis. Trends Cardiovasc Med. 1:1991;216-223.
4. Billingham M. Histopathology of graft coronary disease. J Heart Lung Transplant. 11:1992;S38-S44.
5. Hruban R., Beschorner W., Baurngartner W., Augustine S., Ren H., Reitz B., Hutchins G. Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am J Pathol. 137:1990;871-882.
6. Salomon R.N., Hughes C.C., Schoen F.J., Payne D.D., Pober J.S., Libby P. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol. 138:1991;791-798.
7. Lim T., Liang D., Botas J., Schroeder J., Oesterle S., Yeung A. Role of compensatory enlargement and shrinkage in transplant coronary artery disease. Serial intravascular ultrasound. Circulation. 95:1997;855-859.
8. Schwarzacher S., Uren N., Ward M., Schwarzkopf A., Giannetti N., Hung S., Fitzgerald P., Oesterle S., Yeung A. Determinants of coronary remodeling in transplant coronary disease: a simultaneous intravascular ultrasound and Doppler flow study. Circulation. 101:2000;1384-1389.
9. Tuzcu E., deFranco A., Hobbs R., Rincon G., Bott-Silverman C., McCarthy P., Stewart R., Nissen S. Prevalence and distribution of transplant coronary artery disease: insights from intravascular ultrasound imaging. J Heart Lung Transplant. 14:1995;S202-S206.
10. Yeung A., Davis S., Hauptman P., Kobashigawa J., Miller L., Valantine H., Ventura H., Wiedermann J., Wilensky R. Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. J Heart Lung Transplant. 14:1995;S215-S220.
11. Kapadia S., Nissen S., Tuzcu E. Impact of intravascular ultrasound in understanding transplant coronary artery disease. Curr Opin Cardiol. 14:1999;140-150.
12. Winters G., Schoen F. Graft arteriosclerosis-induced myocardial pathology in heart transplant recipients: predictive value of endomyocardial biopsy. J Heart Lung Transplant. 16:1997;985-993.
13. Libby P., Salomon R., Payne D., Schoen F., Pober J. Functions of vascular wall cells related to the development of transplant-associated coronary arteriosclerosis. Transplant Proc. 21:1989;3677-3684.
14. Libby P., Pober J. Chronic rejection. Immunity. 14:2001;387-397.
15. Libby P., Zhao D-M Allograft arteriosclerosis and immune-driven angiogenesis. Circulation. 107:2003;1237-1239.
16. Sayegh M., Wu Z., Hancock W., Langmuir P., Mata M., Sandner S., Kishimoto K., Sho M., Palmer E., Mitchell R., Turka L. Allograft rejection in a new allospecific CD4+ TCR transgenic mouse. Am J Transplant. 3:2003;381-389.
17. Vella J., Magee C., Vos L., Womer K., Rennke H., Carpenter C., Hancock W., Sayegh M. Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides. Transplantation. 67:1999;1523-1532.
18. Hauptman P., Nakagawa T., Tanaka H., Libby P. Acute rejection: culprit or coincidence in the pathogenesis of cardiac graft vascular disease? J Heart Lung Transplant. 14:1995;S173-S180.
19. Geerling R., DeBruin R., Scheringa M., Bonthuis F., Jeekei J., Izjermanns J., Marquet R. Suppression of acute rejection prevents graft arteriosclerosis after allogeneic aorta transplantation in the rat. Transplantation. 58:1994;1258-1263.
20. Nagano H., Libby P., Taylor M., Hasegawa S., Stinn J., Becker G., Tilney N., Mitchell R. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts. Role of interferon-γ Am J Pathol. 152:1998;1187-1197.
21. Nakagawa T., Sukhova G., Rabkin E., Winters G., Schoen F., Libby P. Acute rejection accelerates graft coronary disease in transplanted rabbit hearts. Circulation. 92:1995;987-993.
22. Billingham M., Cary N., Hammond M., Kemnitz J., Marboe C., McCallister H., Snovar D., Winters G., Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 9:1990;587-593.
23. Libby P. Transplantation-associated arteriosclerosis: potential mechanisms. Tilney N., Strom T., Paul L. Transplantation biology: cellular and molecular aspects. 1996;577-586 Lippincott-Raven, Philadelphia.
24. Biedermann B., Pober J. Human endothelial cells induce and regulate cytolytic T cell differentiation. J Immunol. 161:1998;4679-4687.
25. Biedermann B., Pober J. Human vascular endothelial cells favor clonal expansion of unusual alloreactive CTL. J Immunol. 162:1999;7022-7030.
26. Hasegawa S., Becker G., Nagano H., Libby P., Mitchell R. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts. Origin of inflammatory and vascular wall cells. Am J Pathol. 153:1998;1-11.
27. Hullett D., Geraghty J., Stoltenberg R., Sollinger H. The impact of acute rejection on the development of intimal hyperplasia associated with chronic rejection. Transplantation. 62:1996;1842-1846.
28. Izutani H., Miyagawa S., Shirakura R., Matsumiya G., Nakata S., Shimazaki Y., Matsuda H. Evidence that graft coronary arteriosclerosis begins in the early phase after transplantation and progresses without chronic immunoreaction. Transplantation. 60:1995;1073-1079.
29. Tullius S., Hancock W., Heeman U., Azuma H., Tilney N. Reversibility of chronic renal allograft rejection: critical effect of time after transplantation suggests both host immune-dependent and -independent phases of progressive injury. Transplantation. 58:1994;93-99.
30. Tilney N., Guttmann R. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation. 64:1997;945-947.
31. Hancock W., Buelow R., Sayegh M., Turka L. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med. 4:1998;1392-1396.
32. Russell P., Chase C., Winn H., Colvin R. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol. 152:1994;5135-5141.
33. Shi C., Lee W., He Q., Zhang Z., Fletcher D., Newell J., Haber E. Immunologic basis of transplant associated arteriosclerosis. Proc Natl Acad Sci U S A. 93:1996;4051-4056.
34. Everett J., Hershberger R., Norman D., Chou S., Ratkovec R., Cobanoglu A., Ott G., Hosenpud J. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant. 11:1992;S133-S137.
35. Loebe M., Schuler S., Zais O., Warnecke H., Fleck E., Hetzer R. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Lung Transplant. 9:1990;707-711.
36. Nagano H., Nadeau K., Kusaka M., Heeman U., Tilney N. Infection-associated macrophage activation accelerates chronic renal allograft rejection in rats. Transplantation. 64:1997;1602-1605.
37. Behr T., Feucht H., Richter K., Reiter C., Spes C., Pongratz D., Uberfuhr P., Meiser B., Theisen K., Angermann C. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant. 18:1999;904-912.
38. Collins A., Schneeberger E., Pascual M., Saidman S., Williams W., Tolkoff-Rubin N., Cosimi A., Colvin R. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol. 10:1999;2208-2214.
39. Mauiyyedi S., Crespo M., Collins A., Schneeberger E., Pascual M., Saidman S., Tolkoff-Rubin N., Williams W., Delmonico F., Cosimi A., Colvin R. Acute humoral rejection in kidney transplantation: II Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol. 13:2002;779-787.
40. Mauiyyedi S., Pelle P., Saidman S., Collins A., Pascual M., Tolkoff-Rubin N., Williams W., Cosimi A., Schneeberger E., Colvin R. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol. 12:2001;574-582.
41. Terasaki P. Humoral theory of transplantation. Am J Transplant. 3:2003;665-673.
42. Chow L., Huh S., Jiang J., Zhong R., Pickering J. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection. Circulation. 94:1996;3079-3082.
43. Hosenpud J., Everett J., Morris T., Mauck K., Shipley G., Wagner C. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation. 92:1995;205-211.
44. Libby P., Tanaka H. The pathogenesis of coronary arteriosclerosis ("chronic rejection") in transplanted hearts. Clin Transplant. 8:1994;327-332.
45. Hillebrands J., Klatter F., Hurk Bvd, Popa E., Nieuwenhuis P., Rozing J. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest. 107:2001;1411-1422.
46. Li J., Han X., Jiang J., Zhong R., Williams G., Pickering J., Chow L. Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice. Am J Pathol. 158:2001;1943-1947.
47. Saiura A., Sata M., Hirata Y., Nagai R., Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med. 7:2001;382-383.
48. Shimizu K., Sugiyama S., Aikawa M., Fukukmoto Y., Rabkin E., Libby P., Mitchell R. Host bone-marrow cells are a source of donor intimal smooth muscle-like cells in murine aortic transplant arteriopathy. Nat Med. 7:2001;738-741.
49. Glaser R., Lu M., Narula N., Epstein J. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation. 106:2002;17-19.
50. Grimm P., Nickerson P., Jeffrey J., Savani R., Gough J., McKenna R., Stern E., Ruch D. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med. 345:2001;93-97.
51. Farrar M., Schreiber R. The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol. 11:1993;571-611.
52. Postlethwaite A. Role of T cells and cytokines in effecting fibrosis. Int Rev Immunol. 12:1995;247-258.
53. Roberts A., Sporn M. Physiologic actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors. 8:1993;1-9.
54. Fabry Z., Waldschmidt M., Moore S., Hart M. Antigen presentation by brain microvessel smooth muscle and endothelium. J Neuroimmunol. 28:1990;63-71.
55. Rossi D., Zlotnick A. The biology of chemokines and their receptors. Annu Rev Immunol. 18:2000;217-242.
56. Ward S., Bacon K., Westwick J. Chemokines and T lymphocytes: more than an attraction. Immunity. 9:1998;1-11.
57. Nagano H., Mitchell R., Taylor M., Hasegawa S., Tilney N., Libby P. Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest. 100:1997;550-557.
58. Hansson G. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 21:2001;1876-1890.
59. Laurat E., Poirier B., Tupin E., Caligiuri G., Hansson G., Bariety J., Nicoletti A. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation. 104:2001;197-202.
60. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol. 88:2001;10K-15K.
61. Hansson G., Jonasson L., Holm J., Clowes M., Clowes A. Gamma interferon regulates vascular smooth muscle proliferation and la expression in vivo and in vitro. Circ Res. 63:1988;712-719.
62. Arampatzis C., Lemos P., Tanabe K., Hoye A., Degertekin M., Saia F., Lee C., Ruiter A., McFadden E., Sianos G., Smits P., Giessen Wvd, Feijter Pd, Domburg Rv, Serruys P. Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease. Am J Cardiol. 92:2003;327-329.
63. Eisen H., Tuzcu E., Dorent R., Kobashigawa J., Mancini D., Kaeppler HV-v, Starling R., Sorensen R., Hummel M., Lind J., Abeywickrama K., Bernhardt P. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med. 349:2003;847-858.
64. Mancini D., Pinney S., Burkhoff D., LaManca J., Itescu S., Burke E., Edwards N., Oz M., Marks A. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation. 108:2003;48-53.
65. Luster A. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med. 338:1998;436-445.
66. Colvin B., Thomson A. Chemokines, their receptors and transplant outcome. Transplantation. 74:2002;149-155.
67. El-Sawy T., Fahmy N., Fairchild R. Chemokines: directing leukocyte traffic into allografts. Curr Opin Immunol. 14:2002;562-568.
68. Nelson P., Krensky A. Chemokines, chemokine receptors, and allograft rejection. Immunity. 14:2001;377-386.
69. Nelson P., Krensky A. Chemokines and allograft rejection: narrowing the list of suspects. Transplantation. 72:2001;1195-1197.
70. Shimizu K., Mitchell R. Chemokine-mediated recruitment of inflammatory and smooth muscle cells in transplant-associated arteriosclerosis. Curr Opin Organ Transplant. 8:2003;63-85.
71. Morita K., Miura M., Paolone D., Engeman T., Kapoor A., Remick D., Fairchild R. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J Immunol. 167:2001;2979-2984.
72. Boring L., Gosling J., Chensue S., Kunkel S., Farese R., Broxmeyer H., Charo I. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in CCR2 knockout mice. J Clin Invest. 100:1997;2552-2561.
73. Gu L., Rutledge B., Fiorillo J., Ernst C., Grewal I., Flavell R., Gladue R., Rollins B. In vivo properties of monocyte chemoattractant protein-1. J Leukoc Biol. 62:1997;577-580.
74. Aiello R., Bourassa P., Lindsey S., Weng W., Natoli E., Rollins B., Milos P. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Aretriosler Thromb Vasc Biol. 19:1999;1518-1525.
75. Gosling J., Slaymaker S., Gu L., Tseng S., Zlot C., Young S., Rollins B., Charo I. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest. 103:1999;773-778.
76. Koga S., Auerbach M., Engeman T., Novick A., Toma H., Fairchild R. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine. Mig J Immunol. 163:1999;4878-4885.
77. Gao W., Topham P., King J., Smiley S., Csizmadia V., Lu B., Gerard C., Hancock W. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest. 105:2000;35-44.
78. Horuk R., Shurey S., Ng H., May K., Bauman J., Islam I., Ghannam A., Buckman B., Wei G., Xu W., Liang M., Rosser M., Dunning L., Hesselgesser J., Snider R., Morrissey M., Perez H., Green C. CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model. Immunol Lett. 76:2001;193-201.
79. Horuk R., Clayberger C., Krensky A., Wang Z., Grone H., Weber C., Weber K., Nelson P., May K., Rosser M., Dunning L., Liang M., Buckman B., Ghannam A., Ng H., Islam I., Bauman J., Wei G., Monahan S., Xu W., Snider R., Morrissey M., Hesselgesser J., Perez H. A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. J Biol Chem. 276:2001;4199-4204.
80. Asahara T., Murohara T., Sullivan A., Silver M., Zee Rvd, Li T., Witzenbichler B., Schatterman G., Isner J. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:1997;964-967.
81. Lin Y., Weisdorf D., Solovey A., Hebbel R. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 105:2000;71-77.
82. Campbell J., Efendy J., Campbell G. Novel vascular graft grown within recipient's own peritoneal cavity. Circ Res. 85:1999;1173-1178.
83. Hillebrands J., Klatter F., Dijk Wv, Rozing J. Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med. 8:2002;194-195.
84. Plissonier D., Nochy D., Poncet P., Mandet C., Hinglais N., Bariety J., Michel J. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation. 60:1995;414-424.
85. Kennedy L., Weissman I. Dual origin of intimal cells in cardiac-allograft arteriosclerosis. N Engl J Med. 285:1971;884-887.
86. Majesky M., Giachelli C., Reidy M., Schwartz S. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res. 71:1992;759-768.
87. Schwartz S., Campbell G., Campbell J. Replication of smooth muscle cells in vascular disease. Circ Res. 58:1986;427-444.
88. Cook C., Weiser M., Schwartz P., Jones C., Majack R. Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ Res. 74:1994;189-196.
89. Schwartz S., Foy L., Bowen-Pope D., Ross R. Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells. Am J Pathol. 136:1990;1417-1428.
90. Bochaton-Piallat M., Gabbiani F., Ropraz P., Gabbiani G. Age influences the replicative activity and the differentiation features of cultured rat aortic smooth muscle cell populations and clones. Arterioscler Thromb. 13:1993;1449-1455.
91. Gabbiani G., Kocher O., Bloom W., Vandekerckhove J., Weber K. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest. 73:1984;148-152.
92. Hultgardh-Nilsson A., Krondahl U., Querol-Ferrer V., Ringertz N. Differences in growth factor response in smooth muscle cells isolated from adult and neonatal rat arteries. Differentiation. 47:1991;99-105.
93. Owens G. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 75:1995;487-517.
94. Gibbons G., Dzau V. Molecular therapies for vascular diseases. Science. 272:1996;689-693.
95. Mann M., Gibbons G., Kernoff R., Diet F., Tsao P., Cooke J., Kaneda Y., Dzau V. Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci U S A. 92:1995;4502-4506.
96. Pittenger M., Mackay A., Beck S., Jaiswal R., Douglas R., Mosca J., Moorman M., Simonetti D., Craig S., Marshak D. Multilineage potential of adult human mesenchymal stem cells. Science. 284:1999;143-147.
97. Simper D., Stalboerger P., Panetta C., Wang S., Caplice N. Smooth muscle progenitor cells in human blood. Circ. 106:2002;1199-1204.
98. Campbell G., Chamley-Campbell J. Invited review: the cellular pathobiology of atherosclerosis. Pathology. 13:1981;423-440.
99. Ross R., Glomset J. The pathogenesis of atherosclerosis (second of two parts). N Engl J Med. 295:1976;369-377.
100. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
101. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 340:1999;115-126.
102. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., Hirai H., Makuuchi M., Hirata Y., Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 8:2002;403-409.
103. Caplice N., Bunch T., Stalboerger P., Wang S., Simper D., Miller D., Russell S., Litzow M., Edwards W. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A. 100:2003;4754-4759.
104. Gerdes N., Sukhova G., Libby P., Reynolds R., Young J., Schönbeck U. Expression of interleukin 18 and functional IL-18 receptor on vascular endothelial cells, smooth muscle cells, and macrophages: implication for atherogenesis. J Exp Med. 195:2002;245-257.
105. Suzuki J., Cole S., Batirel S., Kosuge H., Shimizu K., Isobe M., Libby P., Mitchell R. Tumor necrosis factor receptor-1 and -2 double deficiency reduces graft arterial disease in murine cardiac allografts. Am J Transplant. 3:2003;968-976.